Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00777686 · ClinicalTrials.gov registry record
Measuring Non-Enhancing Glioblastoma Progression
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 7
- Enrollment target
NCT00777686: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00777686 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00777686 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if magnetic resonance imaging with magnetic resonance spectroscopy ("MRI/MRS" scanning) can measure any extra growth in the tumor that does not show up on regular MRI images. This study procedure will be performed on patients with recurrent glioblastoma who are either being treated with chemotherapy that blocks blood vessel growth, or will soon begin this type of chemotherapy.
Interventions
- PROCEDURE MRI/MRS Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-03 |
What the finished NCT00777686 record still lists
NCT00777686 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI/MRS Scan is the first listed.
NCT00777686 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00777686 about?
NCT00777686 is a clinical study titled "Measuring Non-Enhancing Glioblastoma Progression". The goal of this clinical research study is to learn if magnetic resonance imaging with magnetic resonance spectroscopy ("MRI/MRS" scanning) can measure any extra growth in the tumor that does not show up on regular MRI images. This study procedure will be performed on patients with recurrent gliobl...
What is the current status of trial NCT00777686?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2008-08. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00777686?
The interventions under investigation include: MRI/MRS Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00777686?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia